We’re seeking case reports from all AMP subdivisions for potential publication in @captodayonline. Share your #molpath expertise by submitting a case today! https://t.co/i1fU3Sg3sd #pathology#pathtwitter
2020 Highlight: AMP’s Board of Directors voted to grant FREE memberships to all students, residents & fellows for the duration of their training beginning in 2021. There’s never been a better time to join or renew your membership! #molpath#pathtwitter#IDTwitter#Informatics
As promised, here is the video with the explanations, 10 unknown cases fully scanned. For those who love #dermpath and #dermatology from @kiko4docs https://t.co/pEKAzHQNBx
Thank you @RandPaul for introducing the #VitalAct2020 to support lab developed tests for efficient and timely patient care against #COVID19@AMPath community
Deep respect and gratitude from @AMPath to @RandPaul for supporting legislation which recognizes the excellence of #pathologists in CLIA-accredited medical labs to respond rapidly & flexibly with highest quality diagnostic testing for patients #COVID19
AMP applauds US Senator @RandPaul for introducing new legislation to allow molecular pathology professionals to continue advancing and offering laboratory developed testing procedures (LDPs) for patient care. #COVID19 https://t.co/YHQf986PsZ
A rare diagnosis. H&E, CD8, CD4, and CD20 whole slide images. @ariv2013 and I will be talking through this case in our next Scopeside chat. Diagnosis? #dermpath#dermatology#pathology https://t.co/LPSkIzggeq